$RKLB

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS

Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.

Original reporting
Published Aug 11, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Traders can update expectations for Q3 revenue based on management’s $250M-$265M guide, while assessing whether GAAP EPS weakness is largely non-recurring versus signaling broader cost pressure. Backlog and cash provide additional support for funding and execution capacity.

02

Market read

A guidance-backed earnings update with record backlog and cash, plus deal-related transaction costs explaining the GAAP EPS miss.

03

What to watch

Backlog growth and cash build are supportive, but the text does not quantify margins or free cash flow impact from the acquisitions, nor does it provide Neutron schedule risk beyond a target for Q4 2026 tank production delivery.

Relevance 8/10Novelty 8/10Timing: pre-market/early session after-hours earnings release context, with Q3 guidance and integration details referenced for the 5:00 PM ET call

Background

Rocket Lab’s Q2 2026 results are framed around product revenue growth, expanding backlog, and deal-related transaction costs tied to Mynaric, Motiv, and a pending Iridium acquisition.

Company-level read

Ticker impact

$RKLBBullishMedium confidence
Context

Rocket Lab reported Q2 2026 revenue of $234.07M, guided Q3 2026 revenue to $250M-$265M, and cited backlog up 137% to $2.36B.

Expected impact

Near-term bias likely positive on revenue, backlog, and cash, partially offset by GAAP EPS weakness tied to deal costs.

Evidence & confidence

The article provides specific Q2 results, explains the GAAP EPS miss as transaction costs, and includes explicit Q3 revenue guidance and backlog/cash figures, which are direct inputs to valuation and near-term expectations.

Market effects

Reinforces demand and execution strength in the space launch and medium-lift reusable rocket segment via record backlog and Neutron production timing.

No specific regional macro linkage stated beyond US-listed company earnings.

Iridium acquisition and integration signals consolidation in satellite communications supply chains, potentially affecting global launch and space services demand expectations.

Counterpoint

GAAP EPS remains negative and the article highlights transaction costs from acquisitions, so investors may discount near-term profitability quality until integration and Iridium deal economics are clearer.

Key entities

  • Rocket Lab

    Reported Q2 2026 revenue and GAAP EPS, provided Q3 2026 revenue guidance, and discussed backlog, cash, and Neutron production timing.

  • Mynaric

    Acquisition closed in the quarter; transaction costs contributed to GAAP EPS miss.

  • Motiv

    Acquisition closed in the quarter; transaction costs contributed to GAAP EPS miss.

  • Iridium Communications

    Pending acquisition referenced as part of transaction costs and to be detailed on the earnings call.

  • Neutron

    Medium-lift reusable rocket; Stage 1 tank production targeting delivery to the launch pad in Q4 2026.

Related articles

$RKLBMedAI 8/10

Rocket Lab Just Delivered Record Results. So Why Is the Stock Sinking?

Rocket Lab (RKLB) reported Q2 record revenue of $234 million, up 62% year over year, and a net loss of $49 million, or $0.08 per share. Revenue beat consensus ($231.6 million) but loss was wider than expected ($0.03). Backlog rose 137% to $2.36 billion, with $1B+ new contracts and $397 million U.S. Space Force Flatellites deal. Q3 revenue guidance is $250-$265 million.

$RKLBHighAI 8/10

Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

Rocket Lab (NASDAQ:RKLB) is set to report Q2 FY2026 earnings on Aug. 10. Management guided Q2 revenue to $225M-$240M, about 60% YoY growth, supported by a $2.2B backlog and recent defense contract wins including a $266M Space Force suborbital contract and $397M Flatellites award. The article highlights Neutron timing and margin deceleration as key investor focus.

$RKLBMed

Window for 2026 launch debut of Rocket Lab’s Neutron rocket ‘is narrowing’ as development continues – Spaceflight Now

Rocket Lab said in an SEC filing that Neutron’s end-of-year launch window is narrowing, with Stage 1 tank production aligned to a Q4 2026 delivery to the launch pad. Exact timing depends on first-stage qualification and other tests. The company also cited a $397 million US Space Force SB-AMTI contract and a dedicated Kepler mission no earlier than 2028.

$RKLBMed

Rocket Lab Q2 Loss Narrows

Rocket Lab Corp (RKLB) reported Q2 results with revenue up 62% year over year to $234.1 million. Net loss narrowed to $49.3 million, or $0.08 per share, from $66.4 million, or $0.13 per share. For Q3, the company forecast revenue of $250 million to $265 million and gross margin of 29% to 31%.

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS — alphai